Incidental TAC ≥1000 increased all-cause mortality risk 3.11-fold, and CAC ≥400 increased MACE risk 8.67-fold; combined calcifications added no extra prognostic value.
Does the presence of incidental cardiovascular calcifications on screening low-dose chest CT predict long-term all-cause mortality and major adverse cardiovascular events?
Incidental coronary and thoracic aortic calcifications detected on screening low-dose chest CT are strong predictors of MACE and all-cause mortality, respectively, though combining multiple calcification sites does not improve prognostic accuracy over CAC alone.
Absolute Event Rate: 0% vs 0%
Background The prognostic significance of incidental cardiovascular calcifications—including coronary artery calcification (CAC), thoracic aortic calcification (TAC), aortic valve calcification (AVC), and mitral annular calcification (MAC)—detected on non-gated, non-contrast low-dose chest computed tomography (LDCT) remains unclear. Purpose To evaluate the long-term prognostic significance of incidental cardiovascular calcifications detected on screening LDCT. Material and Methods This retrospective cohort study included individuals who underwent LDCT at a single health promotion center between 2007 and 2013. A cardiovascular radiologist quantified CAC, TAC, AVC, and MAC using dedicated software. Multivariable Cox proportional hazards regression was used to assess associations with all-cause mortality (ACM) and major adverse cardiovascular events (MACE), defined as revascularization, myocardial infarction, stroke, or cardiovascular death. Incremental prognostic performance was evaluated using Harrell's concordance index (C-index). Results Among the 2434 included individuals (1863 men; median age = 54.2 years), CAC, TAC, AVC, and MAC were identified in 506 (20.8%), 1215 (49.9%), 159 (6.5%), and 49 (2.0%), respectively. The highest TAC category (≥1000) showed the strongest association with ACM (hazard ratio HR = 3.11, 95% confidence interval CI = 1.57–6.16; P = 0.001). The highest CAC category (≥400) showed the strongest association with MACE (HR = 8.67, 95% CI = 4.46–16.88; P <0.001). However, a combined model incorporating CAC, TAC, AVC, and MAC did not provide significant incremental prognostic value beyond CAC alone for ACM or MACE. Conclusion Incidental TAC was associated with increased long-term risk of ACM, while CAC was associated with MACE. However, their combined incorporation did not provide significant incremental prognostic value.
Lee et al. (Thu,) reported a other. Incidental TAC ≥1000 increased all-cause mortality risk 3.11-fold, and CAC ≥400 increased MACE risk 8.67-fold; combined calcifications added no extra prognostic value.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: